Back to Agenda
Session 4: Are we managing the right risk in the right way?
Session Chair(s)
Magnus Ysander, MD
EU & UK QPPV & Head Pharmacovigilance Excellence, AstraZeneca, Sweden
Speaker(s)
Jane Feron
Risk Management Director, AstraZeneca UK Ltd, United Kingdom
Randip Kahlon
Senior Director, Global Risk Management TA Lead, Bristol Myers Squibb, United Kingdom
Have an account?
